Mycobacterium tuberculosis complex DNA does not exist in atheromatous plaques

New Microbiologica

Volumn 28, Issue 2, 2005, Pages 165-169

  Rota, Simin ^a,e   Tuncer, S ^b   Rota, S ^c   Kanat, O ^d  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b Metis Biotechnology Ltd   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

^d City Hospital   (Turkey)

^e NONE   (Turkey)

Author keywords

Atherosclerosis; M. tuberculosis; PCR; Phospholipid

Indexed keywords

BACTERIAL DNA; BCG VACCINE; CHLOROFORM; PHENOL; PRIMER DNA; PROTEINASE K;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ELECTROPHORESIS; ENDARTERECTOMY; EXTRACTION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PRECIPITATION; TISSUE SECTION;

CORONARY ARTERIOSCLEROSIS; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; TUBERCULOSIS;

MYCOBACTERIACEAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

EID: 21244475584     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. ANDREASEN, J.J., FARHOLT, S., JENSEN, J.S. (1998). Failure to detect Chlamydia pneumoniae in calcific and degenerative arteriosclerotic aortic valves excised during open heart surgery. Acta Pathologica Microbiologica et Immunologica Scandinavica, 106, 717-720.
2. DEGRE, M. (2002). Has cytomegalovirus infection any role in the development of atherosclerosis. Clinical Microbiology and Infection, 8, 191-195.
3. EISENACH, K.D., CAVE, M.D., BATES, J.H., CRAWFORD, J.T. (1990). Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis. The Journal of Infectious Diseases, 161, 977-981.
4. FONG, IW. (2000). Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. Canadian Medical Association Journal, 163, 49-56.
5. GEORGE, J., GREENBERG, S., BARSHACK, I., GOLDBERG, I., KEREN, G., ROTH, A. (2003). Immunity to heat shock protein 65- an additional determinant in intimal thickening. Atherosclerosis, 168, 33-38.
6. GEORGE, J., SHOENFELD, Y, AFEK, A., GILBURD, B., KEREN, P., SHAISH, A., KOPOLOVIC, J., WICK, G., AND HARATS, D (1999). Enhanced Fatty Streak Formation in C57BL/6J Mice by Immunization With Heat Shock Protein-65. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 505-510.
7. GEORGE, J., SHOENFELD, Y., GILBURD, B., AFEK, A., SHAISH, A., HARATS, D. (2000). Requisite Role for Interleukin-4 in the Acceleration of Fatty Streaks Induced by Heat Shock Protein 65 or Mycobacterium tuberculosis. Circulation Research, 86, 1203-1210.
8. GUPTA, S., CAMM, A.J. (1998). Is there an infective aetiology to atherosclerosis? Drugs and Aging, 13, 1-7.
9. HOFFME〉STER, A., ROTENBACHER, D., BODE, G., PERSSON, K., MARZ, W., NAUCK, MA., BRENNER, H., HOMBACH, V., KOEN〉G, W. (2001). Current infection with Helicobacter pylori, but not seropositivity to Chylamydia pneumoniae or cytomegalovirus, is associated with an atherogenic modified lipid profile. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 427-432.
10. HORVATH, R., CERNY, J., BENEDIK, J JR., HOKL, J., JELINKOVA, I., BENEDIK, J. (2000). The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. Journal of Clinical Virology, 16, 17-24.
11. JACKSON, LA., CAMPBELL, LA., Kuo, C.C., RODRIGUEZ, DI., LEE, A., GRAYSTON, J.T. (1997). Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. The Journal of.Infectious.Diseases, 176, 292-295.
12. K〉ECHL, S., EGGER, G., MAYR, M., W〉EDERMAN, C.J., BONORA, E., OBERHOLLENZER, F., MUGGEO, M., XU, Q., WICK, G., POEWE, W., WILLEIT, J. (2001). Chronic Infections and the Risk of Carotid Atherosclerosis Prospective Results From a Large Population Study. Circulation, 103, 1064-1070.
13. LAMB, D.J., FERNS, G.A.A. (2002). The magnitude of the immune response to heat shock protein-65 following BCG immunisation is associated with the extent of experimental atherosclerosis. Atherosclerosis, 165, 231-240.
14. LAURILA, A.L., BLOIGU, A., NAYHA, S., HASSI, J., LEINONEN, M., SAIKKU, P. (1998). Chlamydia pneumoniae antibodies associated with altered serum lipid profile. International Journal of Circumpolar Health, 57, (Suppl. 1), 329-332.
15. MAASS, M., BARTELS, C., KRUGER, S., KRAUSE, E., ENGEL, P.M., DALHOFF, K. (1998). Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease. Atherosclerosis, 140, (Suppl. 1), S25-S30.
16. MAASS , M., KRAUSE, E., ENGEL, P.M., KRUGER, S. (1997). Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis. Angiology, 48, 699-706.
17. MAYR, M., KIECHL, S., WILLEIT, J., WICK, G., XU, Q. (2000). Infections, immunity, and atherosclerosis: associations of antibodies to Chylamidia pneumoniae, Helicobacter pylori and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation, 102, 833-839.
18. MIYASHITATA, N., TOYOTA, E., SAWAYAMA, T., MATSUMOTO, A., MIKAMI, Y., KAWAI, N., TAKADA, K., NIKI, Y., MATSUSHIMA, T. (1998). Association of chronic infection of chlamydia pneumoniae and coronary heart disease in the Japanese. Internal Medicine, 37, 913-916.
19. MUHLESTEIN, J.B., HORNE, B.D., CARLQUIST, J.F., MADSEN, T.E., BAIR, T.L., PEARSON, R.R., ANDERSON, J.L. (2000). Cytomegalovirus Seropositivity and C-Reactive Protein Have Independent and Combined Predictive Value for Mortality in Patients With Angiographically Demonstrated Coronary Artery Disease. Circulation, 102: 1917-1923.
20. PATERSON, D.L., HALL, J., RASMUSSEN, S.J., TIMMS, P. (1998). Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients. Pathology, 30, 169-172.
21. PRYZDIAL E.L.G, WRIGHT F. (1994). Prothrombinase assembly on an enveloped Virus: Evidence That the Cytomegalovirus Surface Contains Procoagulant Phospholipid. Blood, 84, 3749-3757.
22. QAVI, H.B., MELNICK, J.L., ADAM, E., DEBAKEY, M.E. (2000). Frequency of coexistence of cytomegalovirus and Chlamydia pneumoniae in atherosclerotic plaques. Central European Journal of Public Health, 8, 71-73.
23. ROIVAINEN, M., VIIK-KAJANDER, M., PALOSUO, T., TOIVANEN, P., LEINONEN, M., SAIKKU, P., TENKANEN, L., MANNINEN, V., HOVI, T., MANTTARI, M. (2000). Infections, Inflammation, and the Risk of Coronary Heart Disease. Circulation, 101, 252-257.
24. ROTA, S., MCWILLIAM, N.A., BAGLIN, T.P., BYRNE, C.D. (1998). Atherogenic Lipoproteins Support Assembly of the Prothrombinase Complex and Thrombin Generation: Modulation by Oxidation and Vitamin E. Blood, 9, 508-515.
25. SHAH, P.K. (2001). Link between infection and atherosclerosis. Who are the culprits: Viruses, Bacteria, Both, or Neither? Circulation, 103, 5-7.
26. SHOENFELD, Y., SHERER, Y., HARATS, D. (2001). Atherosclerosis as an infectious, inflammatory and autoimmune disease. Trends in Immunology, 22, 293-295.
27. STOLLBERGER, C., FINSTERER, C. (2002). Role of Infectious and Immune Factors in Coronary and Cerebrovascular Arteriosclerosis. Clinical and Diagnostic Laboratory Immunology, 9, 207-215.
28. XU, Q., KIECHL, S., MAYR, M., METZLER, B., EGGER, G., OBERHOLLENZER, F., WILLEIT, J., WICK, G. (1999). Association of Serum Antibodies to Heat-Shock Protein 65 With Carotid Atherosclerosis. Clinical Significance Determined in a Follow-Up Study. Circulation, 100: 1169-1174.
29. ZHOU, Y.F., SHOU, M., GUETTA, E., GUZMAN, R., UNGER, EF., YU ZX., ZHANG, J., FINKEL, T., EPSTEIN, SE. (1999). Cytomegalovirus Infection of Rats Increases the Neointimal Response to Vascular Injury Without Consistent Evidence of Direct Infection of the Vascular Wall. Circulation, 100: 1569-1575.
30. ZHU, J., QUYYUMI, AA., ROTT, D., CSAKO, G., WU, H, HALCOX, J., EPSTEIN SE. (2001). Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation, 103: 1071-1075.